Quaker Chemical VP receives stock awards, tax withholding

Quaker Chemical vice president and Principal Accounting Officer Steven R. Dassing reported routine stock-based compensation activity.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Quaker Chemical vice president and Principal Accounting Officer Steven R. Dassing reported routine stock-based compensation activity. On March 15, 2026, previously granted performance and restricted stock units, plus dividend equivalent rights, were exercised into 302 shares of common stock at a stated price of $0.00 per share.

On the same date, he received new awards of 1,823 restricted stock units and 39 shares of common stock. To cover withholding taxes on these vestings, 130 shares were surrendered at $118.45 per share. After these transactions, he directly holds 368 shares of common stock.

Insider Trade Summary

302 shares exercised/converted

Exercise 12 txns

Insider Dassing Steven R.

Role VP, Principal Acctg. Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	45	$0.00	$0.00
Exercise	Restricted Stock Units	82	$0.00	$0.00
Exercise	Restricted Stock Units	171	$0.00	$0.00
Exercise	Dividend Equivalent Rights	4	$0.00	$0.00
Grant/Award	Restricted Stock Units	557	$0.00	$0.00
Grant/Award	Restricted Stock Units	1,266	$0.00	$0.00
Grant/Award	Common Stock	39	$0.00	$0.00
Exercise	Common Stock	45	$0.00	$0.00
Exercise	Common Stock	82	$0.00	$0.00
Exercise	Common Stock	171	$0.00	$0.00
Exercise	Common Stock	4	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	130	$118.45	$15K

Holdings After Transaction: Restricted Stock Units — 2,292 contracts (Direct); Dividend Equivalent Rights — 0 contracts (Direct); Common Stock — 368 shares (Direct)

Footnotes (9)

F1. Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period.
F2. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.
F3. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024, August 15, 2024 and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.
F4. Shares surrendered by reporting person to satisfy withholding tax obligations upon full or partial vesting of restricted stock, RSUs and PSUs previously granted under the Company's Long-Term Performance Incentive Plan.
F5. On March 15, 2024, the reporting person was granted 134 time-based RSUs, vesting in three annual installments beginning on March 15, 2025.
F6. On August 15, 2024, the reporting person was granted 245 special time-based RSUs, vesting in three annual installments beginning on March 15, 2025.
F7. On March 15, 2025, the reporting person was granted 513 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.
F8. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.
F9. Special time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in two annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Quaker Chemical (KWR) executive Steven R. Dassing report in this Form 4?

He reported routine equity compensation activity, including vested performance and restricted stock units converting into 302 common shares, new grants of 1,823 RSUs and 39 common shares, and 130 shares surrendered to cover tax withholding obligations.

How many Quaker Chemical (KWR) shares did Steven R. Dassing acquire through vesting and exercises?

He acquired 302 shares of Quaker Chemical common stock through the exercise and settlement of previously granted performance stock units, restricted stock units, and dividend equivalent rights that vested based on pre-set plan terms and performance metrics.

What new equity awards did Steven R. Dassing receive from Quaker Chemical (KWR)?

He received new grants totaling 1,823 restricted stock units and 39 shares of common stock. These time-based RSUs were granted under the company’s Long-Term Performance Incentive Plan and are scheduled to vest in future annual installments beginning on specified March dates.

Why were 130 Quaker Chemical (KWR) shares surrendered by Steven R. Dassing?

130 shares of common stock were surrendered at $118.45 per share to satisfy withholding tax obligations. These obligations arose upon full or partial vesting of restricted stock, RSUs, and PSUs that had been granted under Quaker Chemical’s Long-Term Performance Incentive Plan.

How many Quaker Chemical (KWR) shares does Steven R. Dassing hold after these transactions?

Following the reported March 15, 2026 transactions, he directly holds 368 shares of Quaker Chemical common stock. This figure reflects both the new shares acquired from vesting and exercises and the 130 shares surrendered for tax withholding obligations.

How do dividend equivalent rights affect Steven R. Dassing’s Quaker Chemical (KWR) holdings?

Dividend equivalent rights accrued on his RSUs when Quaker Chemical paid dividends. Each right was the economic equivalent of one common share and was settled into 4 shares of common stock in connection with specified RSU vesting installments reported in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/17/2026 - 04:44 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dassing Steven R.

(Last)

(First)

(Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN

19428-2380

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Principal Acctg. Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/15/2026		A		39⁽¹⁾	A	$0	196	D
Common Stock	03/15/2026		M		45	A	⁽²⁾	241	D
Common Stock	03/15/2026		M		82	A	⁽²⁾	323	D
Common Stock	03/15/2026		M		171	A	⁽²⁾	494	D
Common Stock	03/15/2026		M		4	A	⁽³⁾	498	D
Common Stock	03/15/2026		F		130⁽⁴⁾	D	$118.45	368	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	03/15/2026		M			45	⁽⁵⁾	⁽⁵⁾	Common Stock	45	$0	45	D
Restricted Stock Units	⁽²⁾	03/15/2026		M			82	⁽⁶⁾	⁽⁶⁾	Common Stock	82	$0	82	D
Restricted Stock Units	⁽²⁾	03/15/2026		M			171	⁽⁷⁾	⁽⁷⁾	Common Stock	171	$0	342	D
Dividend Equivalent Rights	⁽³⁾	03/15/2026		M			4	⁽³⁾	03/15/2026	Common Stock	4	⁽³⁾	0	D
Restricted Stock Units	⁽⁸⁾	03/15/2026		A		557		⁽⁸⁾	⁽⁸⁾	Common Stock	557	$0	557	D
Restricted Stock Units	⁽⁹⁾	03/15/2026		A		1,266		⁽⁹⁾	⁽⁹⁾	Common Stock	1,266	$0	1,266	D

Explanation of Responses:

1. Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period.

2. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.

3. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024, August 15, 2024 and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.

4. Shares surrendered by reporting person to satisfy withholding tax obligations upon full or partial vesting of restricted stock, RSUs and PSUs previously granted under the Company's Long-Term Performance Incentive Plan.

5. On March 15, 2024, the reporting person was granted 134 time-based RSUs, vesting in three annual installments beginning on March 15, 2025.

6. On August 15, 2024, the reporting person was granted 245 special time-based RSUs, vesting in three annual installments beginning on March 15, 2025.

7. On March 15, 2025, the reporting person was granted 513 time-based RSUs, vesting in three annual installments beginning on March 15, 2026.

8. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

9. Special time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in two annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Steven R. Dassing	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR